Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Greece

Innovation Action · Running

DISARM Disarming the silent threat of ovarian cancer

Coordinator
Erevnitiko Panepistimiako Institouto Systimaton Epikoinonion Kai Ypologiston, Greece
Runs
1 September 2025 to 31 August 2029
Status
Running
EU funding
€12.0m
Total cost
€13.2m
Partners
28 organisations in 12 countries
Type
Innovation Action
Grant agreement
101214318

What the project is doing

In the project's own words, from its summary on CORDIS.

Ovarian cancer (OC) is the most lethal of female cancers, often termed a “silent killer”. DISARM’s overall approach to tackle the significant gaps in hereditary OC management lies in tackling both key elements of risk assessment and early detection. The project will investigate multifactorial risk assessment versus standard practices in 4 EU Member States (MS) (Lithuania, Portugal, Czech Republic, and Greece), and will upscale and validate a set of easy-to-use, highly accurate and affordable technologies in five countries (UK, Lithuania, Portugal, Czech Republic, and Greece).

Several intelligent digital assets will optimally support and enhance our clinical studies, while a range of multifaceted activities will ensure the future uptake and adoption of DISARM solutions. The project aligns with the Innovation Action character of this topic by focusing on both mature technologies that can be upscaled in routine healthcare and on emerging technologies that have already shown a potential to justify larger scale validation activities.

Our ultimate ambition is to holistically investigate the preconditions and set the stage for rolling out proven solutions in routine OC risk assessment, and in parallel to create further evidence for the introduction of novel promising elements in early detection programmes. DISARM gathers 26 partners from 12 countries (10 EU MS, the UK and Canada), thereby exhibiting a significant geographic coverage, strengthening European and international collaboration and ensuring widespread diffusion of the project results.

This action is part of the Cancer Mission cluster of projects on ‘Prevention and Early Detection (early detection heritable cancers)

Topics

Who is involved

OrganisationCityCountryRole
Erevnitiko Panepistimiako Institouto Systimaton Epikoinonion Kai YpologistonAthinaGreeceCoordinator
Ainigma TechnologiesLeuvenBelgiumParticipant
Katholieke Universiteit LeuvenLeuvenBelgiumParticipant
TimelexBruxelles / BrusselBelgiumParticipant
World Ovarian Cancer CoalitionTorontoCanadaParticipant
Erevnitiko Idrima P.l.NicosiaCyprusParticipant
Kypriako Idryma Erevnon Gia Ti Myiki DistrofiaAgios DometiosCyprusParticipant
Fakultni Nemocnice BulovkaPrahaCzechiaParticipant
Univerzita KarlovaPraha 1CzechiaParticipant
Vseobecna Fakultni Nemocnice V PrazePraha 2CzechiaParticipant
1st Ygeionomiki Perifereia Dype AttikisAthinaGreeceParticipant
Elliniki Omospondia Karkinou Ell OkAthinaGreeceParticipant
Ethniko Kai Kapodistriako Panepistimio AthinonAthinaGreeceParticipant
Ethniko Kentro Erevnas Kai Technologikis AnaptyxisThermi ThessalonikiGreeceParticipant
Exus Software Monoprosopi Etairia Periorismenis EvthinisAthinaGreeceParticipant
National Center for Scientific Research ""demokritos""""Agia ParaskeviGreeceParticipant
Phaze Kliniki Erevna & Farmakeftikes Symvoules Anonymi EtaireiaAthinaGreeceParticipant
Universidad De La RiojaLogronoSpainParticipant
Carr Communications LimitedDublinIrelandParticipant
Ey Advisory SpAMilanoItalyParticipant
Lietuvos Respublikos Sveikatos Apsaugos MinisterijaVilniusLithuaniaParticipant
Lietuvos Sveikatos Mokslu UniversitetasKaunasLithuaniaParticipant
Associacao Evita - Cancro HereditarioLisboaPortugalParticipant
Instituto Portugues De Oncologia De Lisboa Francisco Gentil EpeLisboaPortugalParticipant
Voc Diagnostics ABLinkopingSwedenParticipant
Care Across LtdLondonUnited KingdomParticipant
Imperial College of Science Technology and MedicineLondonUnited KingdomParticipant
The University of BirminghamBirminghamUnited KingdomParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI